The researchers want to learn what it’s like to attend healthcare appointments as a caregiver, and how doctors and nurses can better support you. Your feedback will help: Improve how healthcare staff ...

This study is looking at preventing ovarian cancer in women at increased risk by removing the fallopian tubes first and then the ovaries at a later date. Read more about A study to prevent ovarian ...

Please note - this trial is no longer recruiting patients. We hope to add results when they are available. This trial is looking at treating areas of abnormal cells in the lungs with an electric ...

Upper urinary tract urothelial cancer is a rare type of cancer of the lining of the kidney or ureter. It used to be called transitional cell cancer (TCC) of the kidney or ureter. This is because it ...

Caring for the needs of someone with cancer can be a satisfying and positive thing. It can bring loved ones or carers closer to the person with cancer and strengthen the bond between people. For many ...

Cryotherapy is a treatment that uses extreme cold to destroy prostate cancer cells. It is also called cryoablation or cryosurgery. You might have cryotherapy for prostate cancer that hasn't spread ...

In the UK, around 2,200 young people (aged 15 to 24 years) are diagnosed with cancer each year. Young people’s cancers can be different to cancers in children and adults. So they need specialists who ...

Read about the tools and resources that can support GPs to recognise, refer and manage suspected bowel cancer cases Access our two-page bowel cancer guide The Faecal Immunochemical Test (FIT) is a ...

There are many organisations and resources to support you and your children. These can: provide emotional support for you and your children help you to explain cancer and treatment to your children ...

It is a treatment for neuroendocrine tumours (NETs). NETs are a type of neuroendocrine cancer. You take capecitabine as a tablet. You swallow it whole with a glass of water. You usually take the ...

We're calling on everyone from researchers, to regulators, patients and the NHS to integrate fragmented efforts to realise a future where early detection and diagnosis is a routine reality. If we are ...